Augmedix, Inc. (AUGX) Misses Q2 EPS by 3c

Augmedix, Inc. (NASDAQ: AUGX) reported Q2 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $13.66 million versus the consensus estimate of $13.64 million.

For earnings history and earnings-related data on Augmedix, Inc. (AUGX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• AI/ML Innovations plans $2M private placement on the CSE
• Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters